Real-world data show that insulin is one of the most prescribed antidiabetic drugs; in particular, among antidiabetic drug users, insulin use ranges between 10–30% [85,86,87,88], while in newly diagnosed T2DM patients insulin use as a starting treatment ranges between 5–12% [89,90,91]. Here, INS is linked to type 2 diabetes mellitus.